We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cryo-Save | LSE:CRYO | London | Ordinary Share | NL0009272137 | ORD EUR0.10 (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 420.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
TIDMCRYO
RNS Number : 0036K
Cryo-Save Group NV
12 April 2010
12 April 2010
Cryo-Save Group N.V.
Director/PDMR Shareholding
Cryo-Save Group N.V.(AIM/Euronext: CRYO, or 'the Group'), Europe's leading stem
cell bank, has been informed that Mr Marc Waeterschoot, Chief Executive Officer,
purchased 17,296 ordinary shares of Euro 0.10 ('Ordinary Shares') at a price
range between EUR5.66 and EUR5.70 between 7 April and 9 April 2010.
Following these purchases, Marc Waeterschoot is beneficially interested in
1,810,000 ordinary shares, representing approximately 19.60% of the Group's
issued share capital.
Enquiries:
+-------------------------------------+---------------------+
| Cryo-Save Group | +31 (0)575 548998 |
+-------------------------------------+---------------------+
| Marc Waeterschoot, Chief Executive | |
| Officer | |
+-------------------------------------+---------------------+
| Arnoud van Tulder, Chief Financial | |
| Officer | |
+-------------------------------------+---------------------+
| | |
+-------------------------------------+---------------------+
| Daniel Stewart & Company plc | +44 (0) 20 7776 |
| | 6550 |
+-------------------------------------+---------------------+
| Simon Leathers/Emma Earl | |
+-------------------------------------+---------------------+
| | |
+-------------------------------------+---------------------+
| College Hill (UK) | + 44 (0) 20 7457 |
| | 2020 |
+-------------------------------------+---------------------+
| Adrian Duffield/Rozi Morris | |
+-------------------------------------+---------------------+
| | |
+-------------------------------------+---------------------+
| SPJ Financiële Communicatie | +31 (0)20 647 8181 |
| Amstelveen (NL) | |
+-------------------------------------+---------------------+
| Kees Jongsma/Léon Melens | |
+-------------------------------------+---------------------+
About Cryo-Save
With more than 120,000 samples saved, Cryo-Save is the leading stem cell bank in
Europe and one of the fastest growing in the world. Driven by its international
business strategy, Cryo-Save is now represented in 38 countries on three
continents and has state-of-the-art processing facilities in Belgium, Germany,
Dubai, India and France (under construction).
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFSRSEIAIII
1 Year Cryo-Save Chart |
1 Month Cryo-Save Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
